19 June 2013
Keywords: bayer, extends, support, hemophilia, prophylaxis, study, biological
Article | 19 July 2004
Bayer Biological Products, a US unit of Germany's Bayer, is extendingits support for a landmark study evaluating the treatment differences
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2004
12 July 2004
© 2013 thepharmaletter.com